Literature DB >> 23896240

Current outcome of esophagectomy in the very elderly: experience of a German high-volume center.

Michael Schweigert1, Norbert Solymosi, Attila Dubecz, Rudolf J Stadlhuber, Dietmar Ofner, Hubert J Stein.   

Abstract

Operative management of esophageal carcinoma in the very elderly is still controversially discussed. It is not yet decided whether the risk warrants the procedure. The aim of this study is to analyze the outcome of esophagectomy for esophageal cancer in the very elderly. Factors influencing the clinical course and determining the outcome are identified. A retrospective study 292 consecutive cases of esophagectomy for nonmetastatic esophageal cancer at a German tertiary referral hospital between 2004 and 2011 were reviewed. Two age groups (75 years or older and younger than 75 years) were formed. The mean age was 63 years. Altogether 45 patients were 75 years or older. There were no significant differences in American Society of Anesthesiologists score, operative procedure, or in the frequency of anastomotic leakage between the age groups. However, very elderly patients with anastomotic leak had an eight times higher risk for fatal outcome than the very elderly without leak (odds ratio [OR], 8.54; 95% confidence interval [CI], 1.0 to 112.18; P = 0.025). Moreover, the odds for postoperative death were five times higher in very elderly patients with leak than in younger patients sustaining anastomotic leakage (OR, 5.67; 95% CI, 0.67 to 73.83; P = 0.046). In general, the very elderly had a three times higher risk for a fatal outcome (OR, 3.30; 95% CI, 1.37 to 7.86; P = 0.008). In-hospital mortality of the very elderly was 11 out of 45 compared with 8 per cent (20 of 247) in the younger group. Fatal outcome was more often caused by medical (seven) than by surgical complications (four cases). The remaining 34 patients recovered well. Very elderly patients undergoing esophagectomy have no elevated risk for occurrence of surgical complications, whereas the mortality of these complications is much higher. Improved outcome is achievable by timely management of postoperative surgical as well as medical complications. Notwithstanding the increased mortality, esophagectomy should be considered in thoroughly selected very elderly patients with curable esophageal carcinoma.

Entities:  

Mesh:

Year:  2013        PMID: 23896240

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  5 in total

1.  Increasing age is a predictor of short-term outcomes in esophagectomy: a propensity score adjusted analysis.

Authors:  Christopher C Stahl; Dennis J Hanseman; Koffi Wima; Jeffrey M Sutton; Gregory C Wilson; Samuel F Hohmann; Shimul A Shah; Daniel E Abbott
Journal:  J Gastrointest Surg       Date:  2014-05-28       Impact factor: 3.452

2.  Esophagectomy for cancer in octogenarians: should we do it?

Authors:  Elizabeth Paulus; Caroline Ripat; Vadim Koshenkov; Angela T Prescott; Kiran Sethi; Heather Stuart; Gregory Tiesi; Alan S Livingstone; Danny Yakoub
Journal:  Langenbecks Arch Surg       Date:  2017-03-16       Impact factor: 3.445

3.  Original scoring system for predicting postoperative morbidity after esophagectomy for esophageal cancer.

Authors:  Naoya Yoshida; Yoshifumi Baba; Masayuki Watanabe; Satoshi Ida; Takatsugu Ishimoto; Ryuichi Karashima; Shiro Iwagami; Yu Imamura; Yasuo Sakamoto; Yuji Miyamoto; Hideo Baba
Journal:  Surg Today       Date:  2014-07-06       Impact factor: 2.549

Review 4.  Esophageal Cancer in Elderly Patients, Current Treatment Options and Outcomes; A Systematic Review and Pooled Analysis.

Authors:  Styliani Mantziari; Hugo Teixeira Farinha; Vianney Bouygues; Jean-Charles Vignal; Yannick Deswysen; Nicolas Demartines; Markus Schäfer; Guillaume Piessen
Journal:  Cancers (Basel)       Date:  2021-04-27       Impact factor: 6.639

5.  Outcomes of curative esophageal cancer surgery in elderly: A meta-analysis.

Authors:  Nikolaj S Baranov; Cettela Slootmans; Frans van Workum; Bastiaan R Klarenbeek; Yvonne Schoon; Camiel Rosman
Journal:  World J Gastrointest Oncol       Date:  2021-02-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.